Sunil Kumar Joshi (Sunil K Joshi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Hiv Infected Patients

Tyrosine Kinase

Liquid Chromatography Tandem Mass Spectrometry

Top Venues

Expert review of proteomics

American journal of hematology

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Sunil Kumar Joshi, Cristina E Tognon, Brian J Druker, Karin D Rodland
Oncoproteomic profiling of AML: moving beyond genomics. Expert review of proteomics 19 (7-12) (2023)
Sunil Kumar Joshi, Cristina E Tognon, Brian J Druker, Karin D Rodland
Oncoproteomic profiling of AML: Moving beyond genomics. Expert review of proteomics (2023)
Sunil Kumar Joshi, Cristina E Tognon, Brian J Druker, Karin D Rodland
Oncoproteomic profiling of AML: moving beyond genomics. Expert review of proteomics 19 (7-12) (2023)
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Sunil Kumar Joshi, Tamilla Nechiporuk, Ariane Huang, Charles A Dibb, Akosha Taylor, Daniel Bottomly, Shannon K McWeeney, Jessica Minnier, Curtis A Lachowiez, Jennifer N Saultz, Ronan T Swords, Anupriya Agarwal, Bill H Chang, Brian J Druker, Jeffrey W Tyner
Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy. Blood cancer discovery (2023)
Sunil Kumar Joshi, Cristina E Tognon, Brian J Druker, Karin D Rodland
Oncoproteomic profiling of AML: moving beyond genomics. Expert review of proteomics (2023)
Sunil Kumar Joshi, Cristina E Tognon, Brian J Druker, Karin D Rodland
Oncoproteomic profiling of AML: moving beyond genomics. Expert review of proteomics 19 (7-12) (2023)
Sunil Kumar Joshi, Cristina E Tognon, Brian J Druker, Karin D Rodland
Oncoproteomic profiling of AML: Moving beyond genomics. Expert review of proteomics (2023)
Sunil Kumar Joshi, Janét Pittsenbarger, Vanessa E Kennedy, Cheryl A C Peretz, Alexander E Perl, Catherine C Smith, Jeffrey W Tyner, Brian J Druker, Elie Traer
The FLT3 N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib. American journal of hematology (2023)
Sunil Kumar Joshi, Setareh Sharzehi, Janét Pittsenbarger, Daniel Bottomly, Cristina E Tognon, Shannon K McWeeney, Brian J Druker, Elie Traer
A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance. American journal of hematology 96 (7) (2021)
Luke Fletcher, Sunil Kumar Joshi, Jennifer Dunlap
Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date. Cancer management and research 12 (2020)
Sunil Kumar Joshi, Jamie M Keck, Christopher A Eide, Daniel Bottomly, Elie Traer, Jeffrey W Tyner, Shannon K McWeeney, Cristina E Tognon, Brian J Druker
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia. Leukemia 34 (10) (2020)
Steven A Yukl, Philipp Kaiser, Peggy Kim, Sushama Telwatte, Sunil Kumar Joshi, Mai Vu, Harry Lampiris, Joseph K Wong
HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. Science translational medicine 10 (430) (2019)